Dr. Anitha S. Nallari
Claim this profileColumbus Oncology and Hematology Associates
Studies Cancer
Studies Renal Cell Carcinoma
3 reported clinical trials
6 drugs studied
Area of expertise
1Cancer
HER2 positive
ER positive
Stage IV
2Renal Cell Carcinoma
Stage IV
Affiliated Hospitals
Clinical Trials Anitha S. Nallari is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
More about Anitha S. Nallari
Clinical Trial Related10 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Anitha S. Nallari has experience with
- Nivolumab
- Ipilimumab
- Cabozantinib
- Biospecimen Collection
- Trastuzumab Emtansine
- Tucatinib
Breakdown of trials Anitha S. Nallari has run
Renal Cell Carcinoma
Soft Tissue Sarcoma
Bone Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anitha S. Nallari specialize in?
Anitha S. Nallari focuses on Cancer and Renal Cell Carcinoma. In particular, much of their work with Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Anitha S. Nallari currently recruiting for clinical trials?
Yes, Anitha S. Nallari is currently recruiting for 2 clinical trials in Dublin Ohio. If you're interested in participating, you should apply.
Are there any treatments that Anitha S. Nallari has studied deeply?
Yes, Anitha S. Nallari has studied treatments such as Nivolumab, Ipilimumab, Cabozantinib.
What is the best way to schedule an appointment with Anitha S. Nallari?
Apply for one of the trials that Anitha S. Nallari is conducting.
What is the office address of Anitha S. Nallari?
The office of Anitha S. Nallari is located at: Columbus Oncology and Hematology Associates, Dublin, Ohio 43016 United States. This is the address for their practice at the Columbus Oncology and Hematology Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.